TAS-102 in Combination With Regorafenib or Fruquintinib for Third-line and Above Advanced Colorectal Cancer
Clinical trial NCT05993702 · UNKNOWN
Trial details
- NCT number
- NCT05993702
- Sponsor
- China Medical University, China
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-01
- Primary completion
- 2024-06-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.